Mike Raab
About Mike Raab
Mike Raab is the President and CEO with extensive experience in the biotech and pharmaceutical industries, previously serving as a partner at New Enterprise Associates and holding senior roles at Genzyme Corporation.
Mike Raab - President & Chief Executive Officer
Mike Raab is the President and Chief Executive Officer. His leadership role involves overseeing the company's strategic direction and operational management. Raab brings extensive experience from his previous positions, making him a valuable asset in steering the organization towards achieving its goals in the competitive biotech and pharmaceutical industry.
Mike Raab's Role at New Enterprise Associates (NEA)
Before his current role, Mike Raab was a partner at New Enterprise Associates (NEA). At NEA, he specialized in healthcare investments with a focus on the biotechnology and pharmaceutical sectors. His expertise contributed significantly to the firm's investment strategies and portfolio companies.
Mike Raab's Experience at Genzyme Corporation
Mike Raab served as senior vice president, therapeutics and general manager of the renal division at Genzyme Corporation, a Sanofi company. During his tenure, he launched and grew the sales of sevelamer, a leading phosphate binder for the treatment of hyperphosphatemia, achieving over $1.0 billion in worldwide sales in 2013. Additionally, he played a vital role in the global launch of Genzyme's therapies for Gaucher disease, including Ceredase and Cerezyme.
Mike Raab's Background in Biotech and Pharmaceutical Industries
Mike Raab spent 15 years in various commercial and operating leadership roles in the biotech and pharmaceutical industries before joining NEA. His extensive background includes positions in business development and sales and marketing at Repligen and Bristol-Myers. This wealth of experience provided Raab with a solid foundation for his subsequent roles and contributions to the industry.
Education and Professional Background of Mike Raab
Mike Raab received his Bachelor of Arts (B.A.) degree from DePauw University. His education, combined with years of hands-on experience in the biotech and pharmaceutical sectors, has equipped him with the knowledge and skills necessary to lead and innovate in his field.